In July, Tonix Pharmaceuticals' short interest rose 30.4%, with 560,400 shares shorted.

Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) saw its short interest rise 30.4% in July, with 560,400 shares shorted (2.7% of total shares) and a days-to-cover ratio of 0.3 days. StockNews.com gave a "sell" rating, while Alliance Global Partners upgraded to a "buy" and increased their price objective to $11.00. The company focuses on therapeutics for human diseases.

August 17, 2024
3 Articles

Further Reading